4
Changes in Ownership
Armata Pharmaceuticals, Inc. Filed Acc 0001104659-21-042628
Options or other derivatives
- Chief Financial Officer acquired 56,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Martin Steven Robert Chief Financial Officer | 2021-03-25 | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | D: show line 1 in the form |
Loading xslF345X03/tm2111079-1_4seq1.xml…